Research Antibodies and Reagents Market Worth $14.56 billion by 2025
17 Feb 2020 • by Natalie Aster
Meticulous Research published a research report titled “Research Antibodies and Reagents Market by Product (Reagent [Sample Preparation (Media, Probe, Buffer), Antibody Production Reagent], Antibody [Type, Source, Research Area]), Technology (Western Blot, ELISA), Application, End User -Global Forecast to 2025”. According to this latest publication from Meticulous Research®, the global research antibodies and reagents market is expected to grow at a CAGR of 6% from 2019 to reach $14.56 billion by 2025. The growth in research antibodies and reagents market is mainly attributed to rising proteomics & genomics research studies, increase in the funding for research activities, and growing industry-academia collaborations. In addition, factors such as rising demand for protein therapeutics and personalized medicine, rising investment and focus on the area of stem cell research, growing need for new biomarker identification, and significant growth opportunities from emerging Asia-Pacific and Latin-America markets supports the growth of this market. However, high cost & time related to identification and development of potential antibodies are the key factors expected to hinder the adoption of research antibodies and reagents.
Research Antibodies and Reagents Market: Future Outlook
The global research antibodies and reagents market study presents, historical market data in terms of values (2017 and 2018), estimated current data (2019), and forecasts for 2025-by product (reagents [sample preparation, antibody production], antibodies [by type, production, source, research area]), technology (western blot, immunohistochemistry, enzyme linked immunosorbent assays, multiplex immunosorbent assays, immunofluorescence, immunoprecipitation, flow cytometry, others), application (proteomics, drug discovery & development, genomics), end user (pharmaceutical & biotechnology industry, academic & research institutes, contract research organizations), and geography. The study also evaluates industry competitors and analyzes their market at a global and regional level.
Based on product, reagents segment accounted for the largest share of the overall research antibodies and reagents market in 2019 and is slated to grow at the fastest CAGR during the forecast period. The large share of this segment is mainly attributed to the recurrent use of reagents in many research assays and techniques, increasing focus towards understanding of molecular basis of diseases, and increasing demand for technologically advanced reagents during research.
Based on technology, western blot is estimated to account for the largest share of the overall research antibodies and reagents market in 2019. This is mainly attributed to increasing focus on biomedical research for initiating developments in diagnosis and therapy, rising funding for biomarker discovery, and rising demand for antibody & cell-based products.
Based on application, proteomics research segment is estimated to hold the largest share of the overall research antibodies and reagents market in 2019. This is attributed to increase in search for ideal drug candidates, need for designing of more effective drugs, and high adoption of proteomics research in assessment of drug efficacy, patient response, and analysis of antibody associated reactions.
Based on end user, pharmaceutical and biotechnology companies commanded the largest share of the overall research antibodies and reagents market in 2019. This is mainly due to high usage of research antibodies & reagents in the proteomics research and drug discovery and development studies. Rising focus of industry players towards development of innovative therapeutics for chronic diseases is contributing to the growth of this market.
This research report analyzes major geographies and provides comprehensive analysis for North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and RoAPAC), Latin America, and Middle East & Africa. North America accounted for the largest share of the global research antibodies and reagents market, followed by Europe and Asia-Pacific regions. However, Asia Pacific region is expected to grow at the fastest CAGR during the forecast period. The large share of North America is mainly attributed to increasing investments by pharmaceutical and biotechnology companies for drug discovery, increasing government funding, increase in the availability of funds for research from various public and private sector organizations, rising focus on proteomics and genomics research, and increasing prevalence & incidence of chronic illness with expanding proportion of elderly population.
The key players operating in the global research antibodies and reagents market are Abcam plc (U.K.), Merck KGaA (Germany), Cell Signaling Technology, Inc. (U.S.),GE Healthcare (U.S.), Thermo Fisher Scientific Inc. (U.S.),F. Hoffmann La-Roche Ltd (Switzerland), Rockland Immunochemicals Inc. (U.S.), Johnson & Johnson (U.S.), Agilent Technologies, Inc. (U.S.), Eli Lily and Company (U.S.), Becton Dickinson and Company (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), GenScript Biotech Corporation (U.S.), Lonza (Switzerland), Bio-Techne Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Teva Pharmaceutical Industries Limited (Israel), Santa Cruz Biotechnology, Inc. (U.S.), and BioLegend, Inc.(U.S.).
More in-demand research reports by this publisher can be found in the Meticulous Market Research catalogue at MarketPublishers.com.